Therapeutic Segment: Anti-Diabetic
Generic Name: Pioglitazone HCl + Glimepiride
As an adjunct to diet and exercise for the improvement of glycemic control in patients with type 2 diabetes mellitus who are already treated with pioglitazone and a sulfonylurea and whose diabetes is not adequately controlled with glimepiride alone or those patients who have initially responded to pioglitazone alone and require additional glycemic control.
You are about to be redirected to an online retailer’s website. Getz Pharma is not liable for any data exchange on the new website
You will be redirected in 3secs
Disclaimer: "This message (including attachment) is intended solely for the use of the individual or entity whom it is addressed and may contain information that is confidential or privileged. If you are not the intended recipient of this message, you are hereby notified that any use, dissemination, distribution or reproduction of this message is prohibited and that, you must not take any action in reliance on it. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrived incomplete or contain viruses; therefore Getz Pharma (Private) Limited cannot accept legal responsibility for the contents of this message. If you have received this communication in error, please notify the sender or Getz Pharma (Private) Limited at [email protected] immediately and destroy the original message."Close